Back to Search
HEIDI PRINCE, D.O.
D.O.
Anesthesiology Physician
NPI: 1649536996IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
E-9727(AR)6586(OK)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Class of 2016
Research & Publications (20)
The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.
PMID 19625344·Ann Oncol·2010
8-other
Predicting durable remissions following thalidomide therapy for relapsed myeloma.
PMID 19194832·Leuk Lymphoma·2009
3-trial
Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma.
PMID 19147779·Clin Cancer Res·2009
4-observational
Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors.
PMID 19519200·Future Oncol·2009
6-review
Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).
PMID 19423744·Blood·2009
3-trial
Successful treatment of lymphomatoid papulosis with photodynamic therapy.
PMID 19397568·Australas J Dermatol·2009
5-case
Safety and efficacy results from an international expanded access programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patients.
PMID 19371392·Intern Med J·2009
4-observational
Evaluation of a multiplex bead-based screening assay for detection of binding antibodies to interferon-beta.
PMID 19345423·J Neuroimmunol·2009
8-other
Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.
PMID 19273705·J Clin Oncol·2009
2-rct
Frequency of missed cases of probable acute West Nile virus (WNV) infection when testing for WNV RNA alone or WNV immunoglobulin M alone.
PMID 19225078·Clin Vaccine Immunol·2009
8-other
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.
PMID 19220531·Intern Med J·2009
6-review
Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma.
PMID 19197721·Leuk Lymphoma·2009
5-case
Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab.
PMID 19659984·Australas J Dermatol·2009
5-case
Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report.
PMID 19608677·Haematologica·2009
5-case
Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma.
PMID 19038505·Int J Radiat Oncol Biol Phys·2009
8-other
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program.
PMID 19036114·Br J Haematol·2009
3-trial
Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator.
PMID 18987661·Leukemia·2009
3-trial
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma.
PMID 19663825·Br J Haematol·2009
3-trial
Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?
PMID 19638019·Br J Haematol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6161 S YALE AVE
TULSA, OK 74136 - Phone
- (918) 494-0612
Quick Facts
- NPI
- 1649536996
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile